Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Berkshire Hathaway to Buy Lubrizol for $9B in Cash

By Pharmaceutical Processing | March 14, 2011

OMAHA, Nebraska
(AP) — Warren Buffett’s Berkshire Hathaway Inc. is buying specialty chemicals
company Lubrizol Corp. for about $9 billion in cash, making it among Berkshire’s biggest acquisitions.

The companies said Monday that the transaction also includes
about $700 million in net debt. Berkshire will
pay $135 per share, a 28 percent premium to Lubrizol’s closing stock price
Friday of $105.44.

Buffett said earlier this month he was looking for more big
acquisitions to boost Berkshire’s earnings
power. Last year, Berkshire Hathaway acquired railroad Burlington Northern
Santa Fe for more than $26 billion.

“Lubrizol is exactly the sort of company with which we
love to partner — the global leader in several market applications run by a
talented CEO, James Hambrick,” Buffett said in a statement.

Lubrizol makes chemicals for pharmaceutical companies, fuel
additives for gasoline and diesel and other ingredients for the transportation
sector. Last month, it reported that its fourth-quarter profit climbed 17
percent because of a $19 million tax benefit and higher sales. The company’s
revenue grew 11 percent to $1.32 billion.

Berkshire Hathaway, which is based in Omaha, Nebraska,
owns roughly 80 subsidiaries, including insurance, clothing, utility,
furniture, jewelry and corporate jet firms. It also has major investments in
such companies as Coca-Cola Co., Washington Post Co. and Wells Fargo & Co.

Buffett, whose investing decisions are carefully scrutinized
by the world of finance, said earlier this month that while he’s interested in
making acquisitions, it’s hard to find big businesses that fit into Berkshire
Hathaway well. He also noted that businesses that do appeal to him usually
aren’t selling at the right price.

Buffett is an adherent of value investing — focusing on
finding financially sound companies with underpriced shares. He has simple
standards for what he looks for in an investment: easy-to-understand large
companies with a strong competitive advantage that generate cash and
above-average returns on capital.

Berkshire’s biggest
acquisition before BNSF was the $16 billion stock purchase of reinsurance giant
General Re announced in 1998.

Buffett said he tries to close deals quickly partly to avoid
the kind of insider trading a former Goldman Sachs board member has been
accused of engaging in just before Berkshire
invested $5 billion in Goldman in 2008.

Berkshire Hathaway and Lubrizol expect the acquisition to
close in the third quarter. After the deal is complete, Lubrizol will become a
Berkshire Hathaway subsidiary. It will keep its Wickliffe, Ohio,
headquarters and continue to be led by current management.

Both companies’ boards have unanimously approved the buyout,
but it still needs the approval of Lubrizol shareholders.

 

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE